|
|
||||||||
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, Norfolk Place, London W2 1PG, U.K.
Wild-type human p53 and a series of p53 point mutants isolated from Burkitt's lymphoma (BL) cell lines were tested for their ability to inhibit DNA synthesis in a p53-negative BL cell line and to bind and be degraded by the human papillomavirus type 16 E6 protein. All the mutants lost the wild-type ability to inhibit DNA synthesis, demonstrating that they are all functionally altered. Binding to E6 and consequent degradation of the p53 mutants frequently correlated with changed suppressor properties in BL cells.
Received 21 October 1992;
accepted 15 December 1992.
This article has been cited by other articles:
![]() |
C. Capoulade, L. M. Mir, K. Carlier, Y. Lecluse, C. Tetaud, Z. Mishal, and J. Wiels Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides Blood, February 15, 2001; 97(4): 1043 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, P. Chen, K. K. Khanna, S. Scott, M. Gatei, S. Kozlov, D. Watters, K. Spring, T. Yen, and M. F. Lavin Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype PNAS, July 22, 1997; 94(15): 8021 - 8026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |